Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control

Diabetes Research and Clinical Practice
M JansàE Esmatjes

Abstract

To assess the effects of telecare on the results of intensive follow-up in T1D patients with poor metabolic control. After initial evaluation, 40 T1D were randomised to either a Telecare (TG) or Conventional Group (CG). Patients had an intensive 6-month follow-up and helped to make decisions concerning treatment self-management. The TG had 12 appointments: 9 telematic with the GlucoBeep system+3 ambulatory. The CG had 12 outpatient appointments. At 0, 6 (end of study) and 12 months, metabolic control, self-management and quality of life were evaluated. Cost analysis was made at study end. Thirty patients completed the study (16 TG, 14 CG). Intention to treat analysis included 19 TG and 16 CG. Improvement in HbA(1c) was similar in both groups TG: 8.4+/-1.2%; 7.5+/-1.4%; 7.6+/-0.9%, p=0.008; CG: 8.9+/-1.3%; 7.7+/-0.9%; 7.6+/-0.7%, p=0.001; with a decrease in hypoglycaemic events and improvement in self-management and quality of life. Patient costs were lower in the TG versus CG in appointment length (0.25h versus 0.5h). However, 30% of the diabetes team and patient appointments were longer than expected due to technical difficulties: (0.25h versus 1h). Intensive telematic follow-up achieves similar results to those of intensive f...Continue Reading

References

Nov 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·G M LennonC J Bailey
May 8, 1998·Diabetes Care·L F MeneghiniD H Mintz
Jun 18, 2002·BMJ : British Medical Journal·Pamela S WhittenSeth Hellmich
Jul 9, 2002·Computer Methods and Programs in Biomedicine·E J GómezA De Leiva
Mar 29, 2003·Diabetes Care·Roberto E IzquierdoRuth S Weinstock
Apr 30, 2003·Diabetes Care·H Peter ChaseSatish K Garg
Jan 30, 2004·Diabetes Care·Hyuk-Sang KwonKun-Ho Yoon
Dec 25, 2004·Diabetes Care·UNKNOWN American Diabetes Association
Jun 29, 2005·Diabetes Care·Graham T McMahonPaul R Conlin

❮ Previous
Next ❯

Citations

Jun 18, 2009·Diabetes, Obesity & Metabolism·J PolisenaK Palmer
Oct 27, 2009·Cost Effectiveness and Resource Allocation : C/E·Trine S Bergmo
Nov 15, 2013·Journal of Medical Internet Research·Morwenna KirwanMitch J Duncan
Dec 21, 2007·Journal of Medical Internet Research·Fenne VerhoevenMichaël Steehouder
Apr 2, 2014·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Alison JonesSandra Jarvis-Selinger
Feb 18, 2014·Diabetes Technology & Therapeutics·Enric EsmatjesOriol de Solà-Morales
May 16, 2014·Canadian Journal of Diabetes·Helen JonesCatherine Yu
Sep 6, 2011·Diabetes & Metabolism·S FrancG Charpentier
Aug 18, 2009·The Nursing Clinics of North America·Phensiri DumrongpakapakornHeidi Donovan
Jun 16, 2015·Journal of Diabetes and Metabolic Disorders·H RiaziL Shahmoradi
Sep 17, 2009·Pediatric Diabetes·Catherine PihokerGeorgeanna J Klingensmith
Dec 11, 2008·Pediatric Diabetes·Catherine PihokerGeorgeanna J Klingensmith
May 23, 2012·Journal of Advanced Nursing·Hilde SolliRagnhild Hellesø
May 1, 2015·International Journal of Endocrinology and Metabolism·Lan DengHugh D Tildesley
Dec 3, 2014·The Medical Clinics of North America·Hugh D TildesleyStuart A Ross
Apr 30, 2016·International Journal of Technology Assessment in Health Care·Mitchel van EedenSilvia M A A Evers
Jun 2, 2010·Journal of Diabetes Science and Technology·Fenne VerhoevenLisette van Gemert-Pijnen
Nov 30, 2011·Nature Reviews. Endocrinology·Beate KargesReinhard W Holl
Jul 8, 2010·Health Affairs·Ronald F Dixon
Aug 21, 2018·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Huidi TcheroEmmanuel Rusch
Sep 8, 2015·The Cochrane Database of Systematic Reviews·Gerd FlodgrenSasha Shepperd
Oct 13, 2021·Journal of Diabetes Science and Technology·Leslie A Eiland, Andjela Drincic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.